Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Report in secondary literature (peer reviewed)

Data source

Reference Type:
secondary source
Habs, H. et al.
Bibliographic source:

Materials and methods

Study type:
case report
GLP compliance:
not specified

Results and discussion

Applicant's summary and conclusion

Executive summary:

Although human exposure to aluminium is widespread, hypersensitivity has been

reported following exposure to some aluminium compounds in only a few cases, either after dermal application or parenteral administration. A case of contact sensitivity to aluminium was reported in Sweden. The patient had regularly been using an aluminium chloride roll-on antiperspirant and developed an itchy dermatitis in the axillae. Patch-tests with aluminium chloride were positive. Contact allergy to aluminium also occurred in a patient hyposensitized with aluminium-precipitated grass pollen. Two cases of contact allergy to aluminium after use of topical medications containing aluminium acetotartrate have been reported. Childhood immunization with an aluminium-bound vaccine can lead to delayed hypersensitivity to aluminium. Children who had had previous injections with these vaccines showed positive patch-tests to aluminium chloride. In Denmark a follow-up study was made of 202 children (age 6-15 years) who had received hyposensitization therapy with various aluminium-containing extracts (subcutaneous application) for an average of 3 years. One to three years after cessation of hyposensitization, 4% (13 children) still had severely pruriginous treatment-resistant subcutaneous nodules in their forearm (application site). Six of these 13 children were patch-tested and four reacted positively on aluminium chloride administration.